|
|
|
|
|
|
|
|
WYIS
> Schedule of Seminar, April-May 2014 |
Please
click the following
mark. |
Ÿ
April 2014 |
2
Apr |
Break |
9
Apr
|
Chairperson:
Satou
Main Discusser
Group: D
Francis
Mwimanzi, D1 (Ueno Project Laboratory)
IDENTIFICATION OF CLINICAL PRESENTATIONS,
ACCOMPANYING DIAGNOSIS IN SICKLE CELL DISEASE PATIENTS IN PANGANI
DISTRICT HOSPITAL
Xiaoming
Sun, D4 (Takiguchi Project Laboratory)
Superimposed epitopes restricted by the same
HLA molecule drive distinct HIV-specific CD8+ T cell repertoires |
16
Apr |
Break:
Special Lectures on AIDS I |
23
Apr |
Break:
Special Lectures on AIDS II |
30
Apr
|
Chairperson:
Sakai
Main Discusser
Group: A
MD Abu
Osman, D3 (Suzu Project Laboratory)
M-CSF reduces cytokine-mediated anti-HIV-1
activity of IL-32 in macrophages
Kristel
Paola Ramirez Valdes, D4 (Matsushita Project Laboratory)
Complementary and synergistic activities of
anti-V3, CD4bs and CD4i antibodies against HIV-1 isolated from a single
individual |
|
Ÿ
May 2014 |
7
May
|
Chairperson:
Ariumi
Main Discusser
Group: B
Ryusho
Kariya, D4 (Okada Project Laboratory)
HAMLET AND BAMLET INDUCE CELL DEATH OF PRIMARY
EFFUSION LYMPHOMA
Zhansong
Lin, D3 (Takiguchi Project Laboratory)
The effect of co-expression of KIRs
and their HLA ligands on HIV-1 control |
14
May
|
Chairperson:
Kuwata
Main Discusser
Group: C
Michihiro
Hashimoto, D3 (Suzu Project Laboratory)
The Preferential Activation of Anti-inflammatory
M2-type Macrophages by HIV-1 Nef is mediated by TAK1 and macro-pinocytosis.
Takeshi
Nishijima, D4 (Oka-Gatanaga Project Laboratory)
Illicit drug use among people with
HIV-1 infection in Japan and its sequelae
|
21May |
Break:
Special Lectures on AIDS III |
28
May
|
Chairperson:
Monde
Main Discusser
Group: D
Yasuhiro
Maruta, D3 (Matsushita Project Laboratory)
Post-attachment neutralization by single-chain
variable fragment (scFv) from an anti-V3 monoclonal antibody with
cross-reactivity.
Mohammad
Arif Rahman, D3 (Oka-Gatanaga Project Laboratory)
Different effect of drug-resistant mutations
on CTL recognition between HIV-1 subtupe B and subtype A/E infections
|
|
|
|
|
|
|